Resources

Personalized Medicine at FDA: 2016 Progress Report


Personalized Medicine at FDA: 2016 Progress Report
(PDF)

Background

DownloadPersonalized Medicine at FDA: 2016 Progress Report demonstrates that in 2016, for the third year in a row, personalized medicines accounted for more than 20 percent of the new molecular entities (NMEs) approved by the U.S. Food and Drug Administration (FDA). The report lists the six personalized medicines approved in 2016 and underlines that nearly one of every four drugs the agency approved from 2014 to 2016 is a personalized medicine. Those numbers are a sharp increase from 2005, when personalized medicines accounted for just 5 percent of NME approvals.

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today